Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CD | O00329 | 1/20 | 0.34 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.34 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.34 |
| ▸ | MTOR | P42345 | 1/20 | 0.34 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.34 |
| ▸ | ELANE | P08246 | 1/20 | 0.31 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25663104 | 0.89 | TDO2 (0.37) | PIK3CDPIK3CAPIK3CBMTORPIK3CG | |
| SCHEMBL25663105 | 0.89 | PRKCZ (0.38) | PIK3CDPIK3CAPIK3CBMTORPIK3CG | |
| SCHEMBL25663101 | 0.85 | PIK3CA (0.48) | PIK3CDPIK3CAPIK3CBMTORPIK3CG | |
| SCHEMBL25663259 | 0.85 | PIK3CD (0.34) | PIK3CDPIK3CAPIK3CBMTORPIK3CG | |
| SCHEMBL25663119 | 0.85 | TDO2 (0.40) | PIK3CDPIK3CAPIK3CBMTORPIK3CG | |
| SCHEMBL25663260 | 0.85 | PIK3CD (0.46) | PIK3CDPIK3CAPIK3CBMTORPIK3CG | |
| SCHEMBL26833768 | 0.84 | PIK3CD (0.33) | PIK3CDPIK3CAPIK3CBMTORPIK3CG | |
| SCHEMBL25663102 | 0.84 | NPC1 (0.44) | PIK3CDPIK3CAPIK3CBMTORPIK3CG | |
| SCHEMBL25663177 | 0.84 | HTR2B (0.33) | — | |
| SCHEMBL25663099 | 0.83 | NPC1 (0.39) | PIK3CDPIK3CAPIK3CBMTORPIK3CG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230172057-A1 | HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND OPTOELECTRONIC DEVICE | WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) | 2023-06-01 | — | — | US | disclosed |
| US-20230172057-A1 | HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND OPTOELECTRONIC DEVICE | WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) | 2023-06-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230172057-A1 | HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND OPTOELECTRONIC DEVICE | CHRM1, CHRM2, CHRM4 | PIK3CD 4761/4885PIK3CA 4539/4885PIK3CB 4855/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.